Nivolumab/pembrolizumabParadoxical eruptive cutaneous squamous cell carcinoma: 2 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1807卷 / 1期
关键词：
D O I：
10.1007/s40278-020-79434-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：148 / 148
相关论文
共 50 条
  • [1] Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
    Oro-Ayude, Marcos
    Suh-Oh, Hae Jin
    Sacristan-Santos, Victor
    Vazquez-Bartolome, Patricia
    Florez, Angeles
    CASE REPORTS IN DERMATOLOGY, 2020, 12 (01): : 37 - 41
  • [2] Baricitinib/upadacitinibRecurrence of cutaneous squamous cell carcinoma and lack of efficacy: 2 case reports
    Reactions Weekly, 2025, 2050 (1) : 105 - 105
  • [3] Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab
    Kamaria, M.
    Shea, C. R.
    Chin, R. K.
    Cohen, E. E.
    Maggiore, R.
    Bolotin, D.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (05) : 604 - 607
  • [4] Immunosuppressants/voriconazolePhototoxicity and cutaneous squamous cell carcinoma: 12 case reports
    Reactions Weekly, 2020, 1835 (1) : 210 - 210
  • [5] EtanerceptFirst report of cutaneous squamous cell carcinoma: 7 case reports
    Reactions Weekly, 2002, 896 (1) : 7 - 7
  • [6] Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases
    Veronika Blum
    Beat Müller
    Silvia Hofer
    Esther Pardo
    Kristin Zeidler
    Joachim Diebold
    Klaus Strobel
    Christoph Brand
    Stefan Aebi
    Oliver Gautschi
    European Journal of Dermatology, 2018, 28 : 78 - 81
  • [7] Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases
    Blum, Veronika
    Mueller, Beat
    Hofer, Silvia
    Pardo, Esther
    Zeidler, Kristin
    Diebold, Joachim
    Strobel, Klaus
    Brand, Christoph
    Aebi, Stefan
    Gautschi, Oliver
    EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (01) : 78 - 81
  • [8] ImatinibCutaneous squamous cell carcinoma: 2 case reports
    Reactions Weekly, 2016, 1632 (1) : 156 - 156
  • [9] AzathioprineCutaneous squamous cell carcinoma: 2 case reports
    Reactions Weekly, 2017, 1660 (1) : 72 - 72
  • [10] VemurafenibKeratoacanthoma and squamous cell carcinoma: 2 case reports
    Reactions Weekly, 2017, 1682 (1) : 300 - 300
12345